Evusheld drug approved for use in people aged 12 and older who are immunocompromised or for whom COVID-19 vaccination is not recommended.
Health Canada has authorized a drug developed by AstraZeneca to prevent COVID-19 infections.
Evusheld has been cleared for people aged 12 and older who have a compromised immune system and are unlikely to get an adequate response to a COVID-19 vaccination, or for whom COVID-19 vaccination is not recommended.
The medication contains lab-made antibodies designed to remain in the body for months, which officials say will contain the virus if there is an infection.
The therapy has also been authorized in the United States and has been recommended by the European Medicines Agency.

Oxford OPP Lay Charges After Warrant Execution
Camping Season is Open at Pittock
Application Window Open for Oxford County Grants Program
PJHL Preview - Schmalz Cup Final
Oxford Winds Celebrates 30 Years
Nomination Period Opens for Municipal Election
Theft in Thamesford is Under Investigation
Winning Lotto 6/49 Ticket Sold in Oxford
Thamesford Lions Club Celebrates 65 Years
Yellow Frost Advisory Issued for Oxford
News Poll: Schmalz Cup 2026
Realtors Care Food Drive Returns Next Week
PJHL Playoff Recap - April 29th
Charges Laid After Altercation in Woodstock
New Partnership Protects Land in Oxford
Bomb Threat Unfounded in Woodstock
Big Projects Announced for TVDSB
Tick Season Reminders from Southwestern Public Health
PJHL Playoff Recap - April 28th
Highway Construction Approaching in Burgessville
Comments
Add a comment